<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548986</url>
  </required_header>
  <id_info>
    <org_study_id>OBPM_ABPM2020</org_study_id>
    <nct_id>NCT04548986</nct_id>
  </id_info>
  <brief_title>Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM)</brief_title>
  <acronym>OBPM_ABPM2020</acronym>
  <official_title>Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Neuchatelois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aktiia SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hopital Neuchatelois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the performances of optical blood pressure monitoring device,&#xD;
      Aktiia.product in the context of cardiac rehabilitation program.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 6, 2020</start_date>
  <completion_date type="Anticipated">August 6, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 6, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean absolute error for blood pressure</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>The mean absolute error between the Reference (standard ambulatory blood pressure monitor) and Aktiia.product for systolic (SYS) and diastolic (DIA) blood pressure in mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean error for blood pressure</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>The mean error between the Reference and Aktiia.product for SYS and DIA in mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Standard deviation of the error for blood pressure</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>The standard deviation of the error between Reference and Aktiia.product for SYS and DIA in mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean absolute error for heart rate</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>The mean absolute error between the Reference (standard ambulatory blood pressure monitor) and Aktiia.product for heart rate in bpm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean error for heart rate</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>The mean error between the Reference and Aktiia.product for heart rate in bpm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Standard deviation of the error for heart rate</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>The standard deviation of the error between Reference and Aktiia.product for heart rate in bpm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the impact of ABPM induced stress on BP readings using inferential statistics.</measure>
    <time_frame>1 week</time_frame>
    <description>Aktiia values acquired during the first day (with ABPM) will be compared to values acquired during other days of the week and a t-test will be performed. The analysis will be repeated for night values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of patient's satisfaction for the two devices through a survey with multiple questions</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>10-points likert scale survey, an agree-disagree scale with minimum 0 and maximum 10. Minimum value means strong disagreement, maximum value means strong agreement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the calibration stability of Aktiia OBPM algorithms</measure>
    <time_frame>12 weeks</time_frame>
    <description>Use different calibration points going from 1 to 12 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of systolic and diastolic blood pressure control during a 12 weeks cardiac rehabilitation program</measure>
    <time_frame>12 weeks</time_frame>
    <description>comparison of blood pressure determinations taken at the beginning and at the end of the program in ambulatory settings</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>single arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>single arm study</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aktiia.product</intervention_name>
    <description>The participants wear Aktiia.bracelet for the duration of the cardiac rehabilitation program. The device is initialized once per week.</description>
    <arm_group_label>single arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult subjects (aged between 21 and 65)&#xD;
&#xD;
          -  Subjects fluent in written and spoken French&#xD;
&#xD;
          -  Subjects enrolled in a 12-weeks cardiac rehabilitation program&#xD;
&#xD;
          -  Subjects agreeing to participate&#xD;
&#xD;
          -  Subjects that have signed the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with tachycardia (heart rate at rest &gt; 120bpm)&#xD;
&#xD;
          -  Subjects with atrial fibrillation&#xD;
&#xD;
          -  Subjects with severe heart failure (LVEF&lt;35%)&#xD;
&#xD;
          -  Subjects with severe renal dysfunctions (eGFR &lt; 30mL/min/1.73 m2)&#xD;
&#xD;
          -  Subjects with pheochromocytoma&#xD;
&#xD;
          -  Subjects with Raynaud's disease&#xD;
&#xD;
          -  Subjects with trembling and shivering&#xD;
&#xD;
          -  Subjects with interarm systolic difference &gt; 15 mmHg&#xD;
&#xD;
          -  Subjects with interarm diastolic difference &gt; 10 mmHg&#xD;
&#xD;
          -  Subjects with arm paralysis&#xD;
&#xD;
          -  Women in known pregnancy&#xD;
&#xD;
          -  Subjects with an arteriovenous fistula&#xD;
&#xD;
          -  Subjects with arm amputations&#xD;
&#xD;
          -  Subjects with the upper arm circumference &gt; 64 cm&#xD;
&#xD;
          -  Subjects with the wrist circumference &gt; 22 cm&#xD;
&#xD;
          -  Subjects with the exfoliative skin diseases&#xD;
&#xD;
          -  Subjects with lymphoedema&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cyril Pellaton, MD</last_name>
    <phone>+41 32 713 35 97</phone>
    <email>cyril.pellaton@rhne.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Josep Sola, PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Réseau Hospitalier Neuchâtelois</name>
      <address>
        <city>Neuchâtel</city>
        <zip>2000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyril Pellaton, MD</last_name>
      <phone>+41 32 713 35 97</phone>
      <email>cyril.pellaton@rhne.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>September 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>September 17, 2020</last_update_submitted>
  <last_update_submitted_qc>September 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

